<?xml version="1.0" encoding="UTF-8"?>
<p>To design better live-attenuated candidates, genetically engineered complementary DNA (cDNA) clone-based, rationally attenuated CHIKV strains were more recently developed and successfully tested in animal models [
 <xref rid="pntd.0006919.ref038" ref-type="bibr">38</xref>, 
 <xref rid="pntd.0006919.ref039" ref-type="bibr">39</xref>], including NHP [
 <xref rid="pntd.0006919.ref040" ref-type="bibr">40</xref>]. These vaccines contain very specific and stable mutations, providing better safety profiles compared with earlier live-attenuated vaccines such as 181/clone25, and retaining strong immunogenicity [
 <xref rid="pntd.0006919.ref012" ref-type="bibr">12</xref>].
</p>
